Most men who ask how to come off TRT are asking two questions at once: how bad will the gap feel, and will the system come back. The answers are: worse than the forums admit for about 6 to 10 weeks, and yes for the large majority, but only back to where it started. This guide lays out the timeline formulation by formulation, the restart drugs and the evidence behind each, the men who should not stop, and a plan that uses bloodwork rather than guesswork.
Coming off testosterone therapy means living through a gap: the injected hormone clears over weeks while the pituitary and testes take months to restart. Pooled data from 1,549 men in hormonal contraceptive trials put median sperm recovery at 3.4 months, with 90 percent recovered by 12 months. hCG plus a SERM restored sperm production in 96 percent of men who had shut down on testosterone, in an average of 4.6 months. The catch that no restart drug changes is that a man returns to his own pre-TRT baseline. This guide covers the timeline by formulation, the restart agents, the men who should not stop, and a monitored plan.
Coming off TRT is a decision men over 40 make for reasons that have little to do with the therapy failing: a partner wants a child, hematocrit has climbed for the third time, a new doctor will not prescribe, the cost has become a problem, or a man simply wants to know whether he still needs it. Whatever the reason, the same biology applies. Testosterone therapy suppresses the hypothalamic-pituitary-testicular axis within weeks of the first dose, and the exogenous hormone that has been covering for that suppression clears on a schedule set entirely by the formulation. The gap between the two is what a man feels.
This guide covers what TRT does to natural production and why the shutdown is so fast, how long each formulation takes to leave the body, what the largest recovery datasets show about how long the axis takes to restart on its own, why recovery lands at the pre-treatment baseline rather than above it, what hCG, clomiphene, enclomiphene and tamoxifen do in a restart and how well the evidence supports each, which men should not attempt to stop, and a monitored 6 month plan built around bloodwork at the points where the numbers actually change.
2 to 4 weeks
Time For LH And FSH To Fall To Near Zero After Starting TRT
Exogenous testosterone tells the hypothalamus and pituitary that the body has enough, and luteinizing hormone drops to undetectable levels within about 2 to 4 weeks. The testes stop making testosterone and sperm because the signal that drives them is gone, not because they are damaged. This is why a man who has been on TRT for 6 weeks and one who has been on it for 6 years start the restart from a similar place hormonally
3.4 months
Median Time To Sperm Recovery In 1,549 Men After Stopping Testosterone (Liu 2006, Lancet)
The pooled analysis of 30 male hormonal contraceptive trials found a median of 3.4 months to reach 20 million sperm per mL after the last dose, with 67 percent recovered by 6 months, 90 percent by 12 months, 96 percent by 16 months and 100 percent by 24 months. Older age, longer treatment and longer-acting formulations all slowed recovery
96%
Of Men Recovered Sperm Production On An hCG Plus SERM Restart (Wenker 2015)
In 49 men who had become azoospermic or severely oligospermic on testosterone or anabolic steroids, hCG 3,000 IU every other day combined with clomiphene, tamoxifen or anastrozole restored sperm to the ejaculate in 95.9 percent, in a mean of 4.6 months. hCG restarts the testes directly while the pituitary is still asleep
8 days
Half-Life Of Testosterone Cypionate, Versus 34 Days For Injectable Undecanoate
Cypionate is essentially gone within 4 to 5 weeks of the last injection; enanthate clears slightly faster; transdermal gel clears within days. Injectable undecanoate (Nebido, Aveed) takes 4 to 6 months to clear and pellets 3 to 6 months. The formulation decides when the low point arrives and how long the axis has to restart before it does
Baseline, not better
Where Natural Testosterone Lands After A Successful Restart
A man whose morning testosterone was 280 ng/dL before TRT returns to roughly 280 ng/dL after a successful restart unless the original cause has changed. Weight loss, treated sleep apnea, less alcohol and better sleep can lift that baseline. hCG, clomiphene and enclomiphene do not raise the ceiling; they only speed the return to it
Testosterone therapy switches off natural production within weeks because the hypothalamus and pituitary read blood testosterone as the signal for how much to make, and exogenous testosterone tells them the job is done. The hypothalamus reduces gonadotropin-releasing hormone, the pituitary stops releasing luteinizing hormone and follicle-stimulating hormone, and without LH the Leydig cells in the testes stop producing testosterone, while without FSH and the very high local testosterone that LH normally drives, the Sertoli cells stop supporting sperm production. LH is typically undetectable within 2 to 4 weeks of the first injection. Testicular volume shrinks by roughly a fifth to a third over the following months, which is the visible sign of the same process.
The important consequence for a man planning to stop is that the testes are not broken; they are idle. Every cell needed to make testosterone and sperm is still present in a man with secondary suppression from TRT, which is why recovery is the rule rather than the exception. Two things make it slower. The first is the length of the pipeline: the hypothalamus has to resume pulsing, the pituitary has to rebuild its LH output, the Leydig cells have to respond, and a full cycle of sperm production takes about 74 days plus transit. The second is the exogenous hormone still in the blood, because the axis will not restart while circulating testosterone is telling it not to. That is why the formulation matters more than anything else in the timeline.
How Long Each Testosterone Formulation Takes To Clear After The Last Dose
| Formulation | Approximate Half-Life | Time To Near-Complete Clearance | What It Means For A Restart |
|---|---|---|---|
| Transdermal gel (Androgel, Testim, compounded) | About 1 day after stopping application | 3 to 7 days | Fastest fall. Symptoms of low testosterone can arrive within the first week, and the axis has no lead time. A short hCG bridge is most useful here |
| Testosterone enanthate | About 4 to 5 days | 3 to 4 weeks | Blood levels drop below the natural range around week 2 to 3. Restart agents are usually started 2 to 3 weeks after the last injection |
| Testosterone cypionate | About 8 days | 4 to 5 weeks | The most common TRT ester in the United States. Low point arrives around week 4 to 6. Restart agents usually begin at week 2 to 3, once levels are falling but before the trough |
| Testosterone undecanoate injection (Nebido, Aveed) | About 34 days | 4 to 6 months | Slowest injectable. LH cannot recover until levels drop, so the gap is long but the fall is gentle. Many men switch to cypionate for 8 to 12 weeks before stopping so the restart can be timed |
| Subcutaneous pellets (Testopel) | Continuous release over 3 to 6 months | 3 to 6 months from insertion | No way to stop early short of surgical removal. The restart clock starts when the pellets are exhausted, not when a man decides to stop |
| Oral testosterone undecanoate (Jatenzo, Tlando, Kyzatrex) | Hours | 1 to 3 days | Clears almost as fast as gel. Same short lead time and same argument for a bridge if symptoms are severe |
Natural testosterone recovers to its pre-treatment level within 3 to 6 months for most men after stopping a short-acting formulation, and within 6 to 12 months for men on longer-acting formulations or longer treatment, with a minority taking up to 2 years. The best data on the timeline come from an unusual source. Peter Liu and colleagues pooled the recovery phase of 30 male hormonal contraceptive trials, 1,549 healthy men who had been given testosterone injections or implants specifically to suppress sperm and were then followed as the axis recovered, and published the analysis in The Lancet in 2006. The median time to reach a sperm concentration of 20 million per mL was 3.4 months. The probability of recovery was 67 percent at 6 months, 90 percent at 12 months, 96 percent at 16 months and 100 percent at 24 months. Testosterone and LH recovered ahead of sperm in nearly every case, because the hormone pipeline is shorter than the 74 day sperm cycle.
The same analysis identified what slows recovery, and every factor applies to men over 40 on TRT. Older age at the time of stopping, a longer duration of treatment, a longer-acting formulation, a higher testosterone dose and a lower baseline sperm count all lengthened recovery. A 2017 study from the Lipshultz group at Baylor in Fertility and Sterility found the same in men on actual TRT: each additional year of age and each additional year on testosterone predicted longer time to sperm recovery even with hCG assistance. A 55 year old man who has injected undecanoate for 8 years should expect the upper end of every range. A 42 year old who has used cypionate for 18 months should expect the lower end. Neither should expect nothing.
The Liu population was young, healthy and fertile before treatment, which makes those figures a best case for men over 40. A 2020 study in the Journal of Clinical Endocrinology and Metabolism by Shankara-Narayana and colleagues followed 93 men, comparing current anabolic steroid users, past users and non-users. Past users had recovered LH, FSH and testosterone to the non-user range in most cases, but testicular volume stayed lower, and the recovery took longer than a year in a meaningful fraction. Kanayama and colleagues at Harvard described in Addiction in 2015 a set of men who remained hypogonadal more than a year after stopping, and argued that prolonged post-androgen hypogonadism is underrecognized. Those were mostly steroid users on supraphysiological doses for years, not TRT patients, but the direction is the same: the longer and heavier the suppression, the slower and less certain the return.
No. A successful restart returns a man to his own pre-treatment baseline, and no restart drug raises that ceiling. This is the single most important fact for a man over 40 who started TRT because his morning testosterone was 250 to 320 ng/dL, and it is the fact most often left out of forum restart protocols written by younger men who cycled steroids on top of a healthy axis. The 25 year old who ran a cycle had a baseline of 600 ng/dL to return to. The 48 year old who started TRT for age-related low testosterone, insulin resistance and sleep apnea has a baseline of 280 ng/dL to return to, and every reason his testosterone was low is still present unless he changed it.
The baseline can move, but only through the things that set it. Losing 10 percent of body weight raises total testosterone by roughly 50 to 100 ng/dL in the trial data. Treating sleep apnea with CPAP produces a smaller and less consistent rise. Cutting alcohol from daily to occasional, sleeping 7 hours instead of 5.5, and correcting a vitamin D or zinc deficiency each move the number modestly. A man who spent his 2 years on TRT also losing 15 kg, fixing his sleep and lifting three times a week may find his restart lands at 400 ng/dL rather than 280. A man who changed nothing else will find his restart lands exactly where he started, and the symptoms that sent him to the doctor will return with it.
The Question Before The Protocol
Before choosing between hCG, clomiphene and enclomiphene, a man over 40 should answer why his testosterone was low in the first place and whether that reason has changed. Secondary hypogonadism from obesity, sleep apnea, alcohol, opioids or chronic stress can recover to a better baseline if the driver has been removed. Primary hypogonadism, where the testes themselves cannot respond, does not recover regardless of protocol, and a man with a pre-TRT LH that was already high alongside low testosterone has primary failure and should not expect a restart to work. The pre-treatment labs, if they exist, answer this question before a single dose of anything.
A restart protocol uses two classes of drug that work at different ends of the axis: hCG mimics LH and wakes the testes directly while the pituitary is still suppressed, and the selective estrogen receptor modulators clomiphene, enclomiphene and tamoxifen block estrogen feedback at the hypothalamus and pituitary so that the pituitary resumes making its own LH and FSH. hCG is the fast lever. It binds the same receptor as LH on the Leydig cells and produces a rise in testosterone within days, along with a rise in the intratesticular testosterone that sperm production depends on. Its limitation is that it does nothing for the pituitary; a man on hCG alone has swapped one exogenous signal for another, and stopping hCG without a SERM bridge often reproduces the original gap.
The SERMs are the slow lever. Clomiphene has the longest record: Katz and colleagues at Cornell reported in BJU International in 2012 that 86 men with secondary hypogonadism on clomiphene 25 to 50 mg raised mean total testosterone from 192 to 485 ng/dL, and a 2019 Journal of Urology series of 400 men found the effect held over 3 years with few side effects. Clomiphene is a mixture of two isomers, and the zuclomiphene half has estrogenic activity, a 30 day half-life and a tendency to accumulate, which is the source of the mood and vision complaints some men report. Enclomiphene is the pure trans isomer with none of that, raises LH, FSH and testosterone at 12.5 to 25 mg daily in the Wiehle 2014 phase 2 trials, and clears within a day, which is why many restart protocols now use it instead. Tamoxifen 20 mg works the same way and is a reasonable substitute where enclomiphene is unavailable.
The Restart Agents Compared
| Agent | Where It Acts | Typical Restart Use | Evidence | Cautions |
|---|---|---|---|---|
| hCG (human chorionic gonadotropin) | Testes: mimics LH at the Leydig cell | 1,500 to 3,000 IU subcutaneous every other day for 2 to 6 weeks, started 1 to 3 weeks after the last injection | Wenker 2015: 95.9 percent sperm recovery in 49 men with hCG 3,000 IU EOD plus a SERM, mean 4.6 months. Extensive fertility-clinic use | Raises estradiol along with testosterone; gynecomastia and water retention at higher doses. Does not restart the pituitary, so it must be tapered into a SERM |
| Clomiphene citrate | Hypothalamus and pituitary: blocks estrogen feedback so LH and FSH rise | 25 mg daily or 50 mg every other day for 4 to 12 weeks, then taper | Katz 2012: total testosterone 192 to 485 ng/dL in 86 men. Krzastek 2019: safe over 3 years in 400 men | Zuclomiphene isomer accumulates over weeks; visual disturbance, irritability and low mood in a minority. Raises estradiol in proportion to testosterone |
| Enclomiphene | Same as clomiphene, without the estrogenic isomer | 12.5 to 25 mg daily for 4 to 12 weeks, then taper | Wiehle 2014: dose-dependent rise in LH, FSH and testosterone in men with secondary hypogonadism. Never FDA approved; compounded | Fewer mood and vision effects than clomiphene. Available only from compounding pharmacies in the United States |
| Tamoxifen | Same mechanism as clomiphene; stronger at the breast | 10 to 20 mg daily for 4 to 8 weeks | Older data in male infertility; used in the Wenker 2015 combination. Prevents gynecomastia during hCG | Not usually needed if enclomiphene is available. Small clot risk at higher doses |
| Anastrozole | Blocks aromatase so less testosterone becomes estradiol | 0.25 to 0.5 mg twice weekly, only if estradiol rises above range on hCG | Used as an add-on in the Wenker series. Not a restart agent on its own | Drives estradiol too low if used reflexively; low estradiol costs bone, libido and mood. Most men do not need it |
A man can just stop, and the Liu data describe what happens when he does: 90 percent of men recover within a year with no drugs at all. A restart protocol does not change whether the axis recovers; it changes how long the gap lasts and how the gap feels. For a man on cypionate for 18 months with a fertility goal in the next 6 months, hCG plus a SERM turns a probable 6 to 12 month wait into a probable 3 to 5 month wait, which is the difference the Wenker study measured. For a man stopping because of hematocrit or cost with no fertility goal and a tolerance for feeling flat for a couple of months, enclomiphene alone or nothing at all is reasonable. What no protocol can shorten is the 74 day sperm cycle, which is why sperm counts trail hormone recovery by 2 to 3 months whatever a man takes.
Step 1
Pull the pre-TRT labs
Morning total testosterone, LH and FSH from before the first dose. Low testosterone with low or normal LH is secondary and recoverable. Low testosterone with high LH is primary and will not recover; stopping means living without testosterone
Step 2
Name the reason for stopping
Fertility: hCG plus SERM, start early. Hematocrit or side effects: consider dose reduction or formulation change first, because those often solve the problem without stopping. Cost, access or curiosity: a SERM alone or a plain stop is enough
Step 3
Match the timing to the formulation
Gel or oral: start the restart the week after stopping. Cypionate or enanthate: start 2 to 3 weeks after the last injection. Undecanoate or pellets: switch to cypionate for 8 to 12 weeks first so the restart can be timed, or accept a 4 to 6 month wait
Step 4
Run the protocol with labs at weeks 4, 8 and 12
LH and FSH detectable and rising by week 4 to 6 on a SERM means the pituitary is awake. Testosterone rising to the pre-TRT range by week 8 to 12 means the testes are responding. Semen analysis at month 3 and 6 if fertility is the goal
Step 5
Judge the result at month 6
Testosterone at or above the pre-TRT baseline with acceptable symptoms: stay off, recheck at 12 months. Testosterone back at 250 with the original symptoms: the restart worked, and the underlying problem is still there. That is a decision about TRT, not about the protocol
The low point after stopping cypionate arrives around weeks 4 to 8, when the injected ester has cleared and the axis has not yet caught up, and for most men it feels like the original low testosterone with a sharper edge because the drop is faster than the slow decline that preceded TRT. Fatigue, low libido, fewer morning erections, poorer sleep, irritability, flat mood and a loss of drive in the gym are the common reports, in roughly that order of frequency. Water weight drops in the first two weeks, which reads as fat loss on the scale and as a loss of fullness in the mirror. Strength typically holds for 4 to 6 weeks on the training already banked and then softens. A restart protocol compresses this window; hCG in particular can hold testosterone in the normal range through the weeks the pituitary would otherwise leave empty.
Two things make the gap worse than it needs to be. The first is stopping abruptly from a high dose. A man on 200 mg of cypionate a week with peak levels above 1,200 ng/dL falls further and faster than a man on 100 mg with peaks around 700, and many clinicians taper to a physiological dose for 4 to 8 weeks before the final injection for that reason, although a taper cannot restart the axis and only softens the descent. The second is a hematocrit or estradiol problem that has not been addressed, because the fall in testosterone changes both. Estradiol falls with testosterone and the drop in estradiol is responsible for a good share of the mood and joint complaints; a man who is also on anastrozole should stop it at the same time as the testosterone, not after.
Men with primary hypogonadism, men who have had both testes removed or irradiated, men with pituitary disease or a prior pituitary surgery, and men with Klinefelter syndrome should not attempt a restart, because the tissue that a restart depends on is absent or non-functional and the result is a prolonged period without testosterone that costs bone, muscle and mood for nothing. A pre-TRT LH above the reference range with a low testosterone is the lab signature of primary failure and settles the question. Men over 60 who have been on TRT for a decade or more can recover, but the Liu and Lipshultz data put them at the slow end of every curve and they should plan for a year rather than a season.
There is also a group who can stop but probably should not. A man with osteopenia on his last DEXA loses bone during a prolonged hypogonadal gap. A man with major depression that improved on TRT risks a relapse at the trough. A man whose pre-TRT testosterone was 180 ng/dL with clear symptoms is going back to 180 ng/dL with clear symptoms, and a restart only proves the point. For these men, the better questions are usually whether the problem that prompted stopping can be solved without stopping: hematocrit by dose reduction, more frequent smaller injections or a switch from injections to gel; fertility by adding hCG to TRT rather than stopping TRT; cost by switching from a clinic to a generic cypionate prescription. The hCG-on-TRT approach in particular preserves sperm production in most men without any gap at all, and is the standard answer in fertility clinics for a man on TRT who wants a child.
Weeks minus 4 to 0: Taper and baseline
Weeks 1 to 2: Clearance
Weeks 3 to 6: Start the SERM
Weeks 7 to 12: Taper hCG, hold the SERM
Months 4 to 6: Taper the SERM and judge
A Restart Proves What The Baseline Was, Not What It Could Be
The most common outcome for a man over 40 who comes off TRT with a well-run protocol is a full recovery of LH, FSH and sperm production, a testosterone level within 10 percent of where he started, and a return of the symptoms that made him start. That is a success by every measure the protocol can control. Whether it is the right outcome depends on why he stopped. If the goal was a child, the hCG-on-TRT approach usually gets there without a gap. If the goal was to find out whether he still needs it, the answer is usually the same as it was before, unless something about his weight, sleep, drinking or health has actually changed. If the goal was to solve hematocrit, cost or access, most of those have solutions that do not involve stopping at all.
Continue Reading
HCG on TRT: Testicular Function, Fertility, and What the Signal Is Doing
13 min read
Enclomiphene: The TRT Alternative That Keeps Your Own Factory Running
11 min read
Injections, Gels, Pellets, or Pills: How TRT Delivery Method Changes Everything About Treatment
13 min read